基于网络药理学的枸杞子药理作用及其机制研究

中国医药导刊 ›› 2020, Vol. 22 ›› Issue (1): 28-33.

基于网络药理学的枸杞子药理作用及其机制研究

谭真真,马丽杰,刘颖

内蒙古医科大学

收稿日期:2019-11-26 修回日期:2020-01-13 出版日期:2020-01-31 发布日期:2020-03-20
基金资助:
国家自然科学基金资助项目

Pharmacological Action and Mechanism of Wolfberry Based on Network Pharmacology

Inner Mongolia Medical University

Received:2019-11-26 Revised:2020-01-13 Online:2020-01-31 Published:2020-03-20
Supported by:
蒙药古日古木单、复方对肝损伤的保护作用及JNK通路机制研究

摘要/Abstract

摘要： 目的：采用网络药理学方法对枸杞子成分、靶点、通路、对应疾病进行系统研究。方法：借助TCMSP、GeneCards、UniProt数据库收集枸杞子成分、靶点、对应疾病，通过STRING数据库进行蛋白互作网络分析，并利用DAVID、omicshare平台进行KEGG富集和通路可视化，最后使用Cytoscape软件构建成分、靶点、通路、疾病之间的网络。结果：通过TCMSP、GeneCards、UniProt数据库共收集到枸杞子活性成分45个，靶点203个，疾病24个，疾病主要涉及癌症、高血压、阿尔兹海默症等。使用Cytoscape软件构建成分-靶点网络，筛选主要成分及其靶点。通过DAVID平台，对枸杞子靶点进行KEGG富集分析，筛选到P＜0.05的通路119条，通路按P值由小到大排列，对前30条通路可视化，通路主要涉及TNF、HIF-1、p53、PI3K-Akt、Calcium、Toll-like receptor、Thyroid hormone、FoxO、NOD-like receptor等信号通路，以及癌症、乙肝、利什曼病、白血病等疾病通路。结论：该研究通过构建枸杞子成分-靶点-通路-疾病网络，为枸杞子在临床应用及机制研究方面提供了方向和思路。

Abstract: Objective： To systematically study the components， targets， pathways and corresponding diseases of wolfberry by network pharmacology. Methods： TCMPS、GeneCards and UniProt databases were used to collect wolfberry components、targets、diseases，protein interaction network analysis through STRING database， KEGG enrichment and pathway visualization using DAVID and omicshare platforms， and finally using Cytoscape software to construct a network of targets、pathways and diseases. Results： A total of 45 active components of wolfberry， 203 targets， and 24 diseases were collected by TCMSP、GeneCards and UniProt databases. The diseases mainly involved cancer， hypertension， and Alzheimer′s disease. The component-target network was constructed using Cytoscape software to screen the major components and their targets. Through the DAVID platform， KEGG enrichment analysis was performed on the target of wolfberry， and 119 channels of P<0.05 were screened. The pathways were arranged from small to large by P values， and the first 30 pathways were visualized. The pathway mainly involved TNF、HIF-1、p53、PI3K-Akt、Calcium、Toll-like receptor、Thyroid hormone、FoxO、NOD-like receptor and other signaling pathways， as well as cancer、hepatitis B、leishmaniasis、leukemia and other disease pathways. Conclusion：This study provides a direction and ideas for the clinical application and mechanistic research of wolfberry by constructing a wolfberry component-target-path-disease network.

中图分类号:

R285

谭真真马丽杰刘颖. 基于网络药理学的枸杞子药理作用及其机制研究[J]. 中国医药导刊, 2020, 22(1): 28-33.

TAN Zhenzhen, LIU Ying, MA Lijie. Pharmacological Action and Mechanism of Wolfberry Based on Network Pharmacology[J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2020, 22(1): 28-33.

参考文献

[1]AMAGASE H, FARNSWORTH N R.A review of botanical characteristics, phytochemistry, clinical relevance in efficacy and safety of Lycium barbarum fruit (Goji) [J].Food Research International, 2011, 44 (7) :1702-1717
[2]赵明宇.枸杞子的药理作用及临床应用研究[J].北方药学,2018,15(04):156.
[3]JIN M L, HUANG Q S, ZHAO K, et al.Biological activities and potential health benefit effects of polysaccharides isolated from Lycium barbarum L.[J].International Journal of Biological Macromolecules, 2013, 54 (1) :16-23
[4]XIA G Q, XIN N, LIU W, et al.Inhibitory effect of Lycium barbarum polysaccharides on cell apoptosis and senescence is potentially mediated by the p53 signaling pathway[J].Molecular Medicine Reports, 2014, 9 (4) :1237-1241
[5]LI J, WANG L, LI J, et al.Lycium barbarum polysaccharide attenuates high-fat diet-induced hepatic steatosis by up-regulating SIRT1expression and deacetylase activity[J].Scientific Reports, 2016, 6:36209
[6]Alessandro M , Olga B , Daniele R , et al. Research Progress in the Modification of Quercetin Leading to Anticancer Agents[J]. Molecules, 2017, 22(8):1270-.
[7]Z Ovesná, A Vachálková, K Horváthová. Taraxasterol and beta-sitosterol: New naturally compounds with chemoprotective/chemopreventive effects[J]. Neoplasma, 2004, 51(6):407-414.
[8]Rizzo M T . Cyclooxygenase-2 in oncogenesis[J]. Clinica Chimica Acta, 2011, 412(9-10):0-687.
[9]Cipollone, Francesco, Fazia, Maria Luigia. COX-2 and Atherosclerosis[J]. J Cardiovasc Pharmacol, 47(Supplement 1):S26-S36.
[10]Luo D , Long Y , Chen G J . Cyclooxygenase-2 gene polymorphisms and risk of Alzheimer\"s disease: A meta-analysis[J]. Journal of the Neurological Sciences, 2015:S0022510X1530006X.
[11]刘娜,王沛齐,马丽,米卫东.环氧合酶2与中枢神经系统疾病关系的研究进展[J].人民军医,2016,59(03):306-308.
[12]Shalini S , Dorstyn L , Dawar S , et al. Old, new and emerging functions of caspases[J]. Cell Death and Differentiation, 2015, 22(4):526-539.
[13]Wajant, H, Pfizenmaier, K, Scheurich, P. Tumor necrosis factor signaling[J]. Cell Death and Differentiation, 10(1):45-65.
[14]Chen, G. TNF-R1 Signaling: A Beautiful Pathway[J]. Science, 2002, 296(5573):1634-1635.
[15]Farhan Mohd, Wang Haitao, Gaur Uma,等. FOXO Signaling Pathways as Therapeutic Targets in Cancer[J]. International Journal of Biological Sciences, 13(7):815-827.
[16]Brunet A . Aging and the control of the insulin-FOXO signaling pathway[J]. médecine/sciences, 2012, 28(3):316-320.
[17]Mayer I A , Arteaga C L . The PI3K/AKT Pathway as a Target for Cancer Treatment[J]. Annual Review of Medicine, 2016, 67(1):annurev-med-062913-051343.
[18]Xu W , Yang Z , Lu N . A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition[J]. Cell Adhesion & Migration, 2015, 9(4):1-8.

快速检索引用检索图表检索高级检索